On July 27, 2022 EVERSANA reported to be a Global Sponsor at this year’s Pharma Japan 2022 hosted by Reuters, taking place on 28-29 September (Press release, EVERSANA, JUL 27, 2022, View Source [SID1234617004]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Pharma has entered a new world, where scientific innovation is no longer enough to be successful. This, coupled with looming deregulation and an influx of innovative treatments, means that the time is now for you to put your strategy for the future into action. It’s time to go beyond the medicine and focus on patient value.

EVERSANA is present at Pharma Japan and committed to providing insights and support to our clients during this transformative time in our industry.

Join EVERSANA’s Rob Arnold, Executive Vice President for APAC, on September 28 at 9:10-9:30 JST as he presents the session "Beyond Fortress Japan." In this session, Rob will discuss how Japanese companies can no longer rely on the model of selling in Japan and out-licensing elsewhere. They need to enter at least EU, US and China and they need to do it soon. However, this is fraught with risk and requires alignment and tenacity. EVERSANA will share our thoughts on the emerging entry models based on our client support perspective.

Talk with our business experts to learn more about how our global commercial solutions provide you with the right strategies and tools to help accelerate your speed to market. Click the button below to schedule a meeting. Look for an EVERSANA team member live on the conference networking platform.